Court Unseals Key Evidence in Coventry Filing Showing Abacus Global Management Relied on Short Lapetus Life Expectancy Estimates and Misled Investors
Unsealed court documents in the ongoing litigation between Coventry and Abacus reveal that Ababus relied on Lapetus Solutions life expectancy estimates with a 41.5% actual-to-expected ratio, significantly underperforming the industry standard near 100%. The filings allege Ababus misled investors regarding the independence of the Lewis & Ellis valuation report, claiming it validated portfolio values within 1% while allegedly withholding longer life expectancy estimates and manipulating discount rates.
Key figures
- Lapetus ae ratio
- 41.5%
- Lapetus estimates months
- 72
- Other le estimates months
- 209-248
- Abacus valuation diff claim
- within 1%
- Credit union investment usd
- $500 million
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.